Contents & Topics
Related Information
Collaborative Efforts
The Atlanta Research & Education Foundation is designed to facilitate collaborations between the Department of Veterans Affairs Medical Center in Atlanta and other institutions. We welcome your interest in our facility, personnel, and research capabilities.

Working with the larger research community, AREF is one of the leading foundations in the country devoted to improving research, education, and ultimately healthcare for our nation's Veteran population.

Read More

Search


Investigator Profile Search Results

Save Profile to PDF
Investigator: Cherry Wongtrakool
Phone: (404) 321-6111 ext. 207388
Email: cwongtr@emory.edu
Primary Research Interest: Other
Description of Research: 1) Nicotine is a major component of tobacco smoke that has been shown to affect proliferation and airway development in the lung. We are investigating how nicotine is a causative agent for increased airway hyperresponsiveness through effects on neurogenic signals. In addition, because Th2 inflammation contributes to the pathogenesis of asthma and a subset of patients with COPD, we are investigating whether a novel therapy targeting Th2 inflammation can reverse the airway hyperresponsiveness in an animal model of asthma. 2) T2 inflammation is the most common pathophysiologic mechanism in severe asthma. We are studying whether inhibiting GATA-3 using a novel nanoparticle-based therapeutic could be a viable alternative to oral corticosteroids and biologics. 3) Home-based rehabilitation is a promising alternative to center-based pulmonary rehabilitation for patient with COPD. We are proposing to study two different home-based rehabilitation strategies-a smartphone app delivered pulmonary rehabilitation program and inspiratory muscle training using videoplay with incentive spirometry-based training.
Relevance to VA: Cigarette smoking is prevalent among veterans with a current smoking rate of 35%. Pulmonary diseases such as asthma and chronic obstructive pulmonary disease contribute significantly to healthcare utilization in the VA system. Airway hyper responsiveness is associated with poor asthma control and poorer outcomes in patients with COPD, so understanding the mechanisms responsible for airway hyperresponsiveness may identify novel therapeutic targets to improve treatments for asthma and COPD. 2) Asthma affect 1 in 12 people in the U.S. The prevalence of asthma has increased in Iraq and Afghanistan war veterans from 1.1% in 2003 to 3.1% in 2011 (Pugh et al., Mil Med 2016). Asthmatics with severe asthma are dependent on frequent use of oral corticosteroids which have significant side effects. Therefore, alternative to corticosteroids are desperately needed for veterans with severe asthma. 3) COPD affects an estimated 17% of veterans (Molnar et al. Thorax 2015). Pulmonary rehabilitation is part of the comprehensive management plan for COPD, but many veterans often encounter barriers (financial, transportation, social support) to receiving pulmonary rehabilitation. Therefore, home-based rehabilitation efforts are desperately needed for veterans with COPD

Return to Search Form

Copyright © 2021 AREF. All Rights Reserved.     Privacy Statement      Support